Answers are grounded in this paper and cite their sources.
No discernable differences in protection against symptomatic BA.1 and BA.2 infection were seen with previous infection, vaccination, and hybrid immunity. Vaccination enhanced protection among persons who had had a previous infection. Hybrid immunity resulting from previous infection and recent booster vaccination conferred the strongest protection. (Funded by Weill Cornell Medicine-Qatar and others.).
No takes yet. Share an insight, caveat, or question.
Altarawneh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: